Evercore ISI analyst John Pancari maintained a Buy rating on KeyCorp (KEY – Research Report) yesterday and set a price target of $20.00. The ...

Evercore ISI analyst John Pancari maintained a Buy rating on Zions Bancorporation National Association (ZION – Research Report) yesterday and ...

Julian Emanuel of Evercore ISI says Trump's economic policies will be moderated and influenced by the bond markets. His does not see a significant downturn in the U.S. economy, explaining his S ...

In conclusion, despite the dynamic nature of the data center cooling market, Evercore ISI believes that Vertiv is well-equipped to meet the increasing demand for efficient thermal and power ...

Evercore ISI analyst Amit Daryanani lowered the firm’s March-end quarter estimates for Seagate (STX) after the company filed an 8-K on December 3, noting they are experiencing some delays in ...

Fintel reports that on January 7, 2025, Evercore ISI Group downgraded their outlook for DENTSPLY SIRONA (WBAG:XRAY) from Outperform to In-Line. There are 814 funds or institutions reporting ...

On Tuesday, Evercore ISI analysts downgraded Dentsply Sirona stock from Outperform to In Line, adjusting the price target to $20.00. The decision was influenced by uncertainties surrounding the dental ...

NEW YORK, January 03, 2025--(BUSINESS WIRE)--Evercore (NYSE: EVR) will host its 11th annual Utility CEO Conference in Scottsdale, Arizona, Jan. 8-10, 2025. The power & utilities sector is rapidly ...

Evercore ISI anticipates a 22% growth in the S&P 500 Index to 7,200, up from its current level of 5,940, therefore signaling a great year for the stock market in 2025; among other tech firms, Nvidia ...

Emphasizing the potential of firms positioned to profit from increased corporate use of artificial intelligence, Evercore ISI has released its top software stock recommendations for 2025.

Emphasizing the potential of firms positioned to profit from increased corporate use of artificial intelligence, Evercore ISI has released its top software stock recommendations for 2025. The company ...

Shares of Spero Therapeutics stock opened at $0.96 on Friday. Spero Therapeutics has a 12 month low of $0.95 and a 12 month high of $1.89. The business has a 50-day moving average of $1.20 and a ...